SILK - Silk Road Medical, Inc
NASDAQ
->
Healthcare
->
Medical Devices
Sunnyvale,
United States
Type: Equity
SILK price evolution
SILK
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20.21 | $29.19 | $28.4 | $50.58 |
| Short term investments | $161.26 | $163.67 | $159.96 | $138.64 |
| Net receivables | $23.57 | $21.78 | $21.52 | $19.96 |
| Inventory | $29.88 | $22.07 | $19.07 | $17.18 |
| Total current assets | $240.84 | $240.98 | $233.5 | $230.25 |
| Long term investments | $9.46 | $4.35 | $13.88 | $15.29 |
| Property, plant & equipment | $8.11 | $8.34 | $8.64 | $8.9 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $24.47 | $19.88 | $29.86 | $29.33 |
| Total investments | $170.72 | $168.02 | $173.84 | $153.93 |
| Total assets | $265.31 | $260.86 | $263.36 | $259.59 |
| Current liabilities | ||||
| Accounts payable | $5.68 | $5.09 | $5.34 | $5.27 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $30.28 | $24.02 | $24.1 | $20.87 |
| Long term debt | $75.63 | $75.36 | $75.1 | $74.85 |
| Total noncurrent liabilities | $83.88 | $83.7 | $83.76 | $81.1 |
| Total debt | $75.63 | $75.36 | $75.1 | $74.85 |
| Total liabilities | $114.16 | $107.72 | $107.86 | $101.97 |
| Shareholders' equity | ||||
| Retained earnings | -$399.45 | -$386.44 | -$373.66 | -$360.17 |
| Other shareholder equity | $0.07 | -$0.28 | -$0.33 | $0.08 |
| Total shareholder equity | $151.15 | $153.14 | $155.5 | $157.61 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20.21 | $55.51 | $110.46 | $69.78 |
| Short term investments | $161.26 | $158.32 | $78.02 | |
| Net receivables | $23.57 | $18.01 | $11.83 | $9.07 |
| Inventory | $29.88 | $19.29 | $17.85 | $9.99 |
| Total current assets | $240.84 | $254.9 | $143.33 | $173.33 |
| Long term investments | $9.46 | |||
| Property, plant & equipment | $8.11 | $14.45 | $7.7 | $2.84 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $24.47 | $14.79 | $13.3 | $5.99 |
| Total investments | $170.72 | $158.32 | $78.02 | |
| Total assets | $265.31 | $269.69 | $156.63 | $179.31 |
| Current liabilities | ||||
| Accounts payable | $5.68 | $2.52 | $2.38 | $2.6 |
| Deferred revenue | ||||
| Short long term debt | $3.9 | |||
| Total current liabilities | $30.28 | $24.49 | $26.09 | $19.55 |
| Long term debt | $75.63 | $74.6 | $44.79 | $48.53 |
| Total noncurrent liabilities | $83.88 | $81.32 | $51.3 | $52.26 |
| Total debt | $75.63 | $74.6 | $48.69 | $48.53 |
| Total liabilities | $114.16 | $105.81 | $77.39 | $71.81 |
| Shareholders' equity | ||||
| Retained earnings | -$399.45 | -$343.71 | -$288.7 | -$238.89 |
| Other shareholder equity | $0.07 | -$0.17 | $0.04 | |
| Total shareholder equity | $151.15 | $163.88 | $79.24 | $107.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $47.27 | $44.44 | $45.3 | $40.13 |
| Cost of revenue | $12.47 | $12.05 | $13 | $12.53 |
| Gross Profit | $34.8 | $32.38 | $32.29 | $27.61 |
| Operating activities | ||||
| Research & development | $10.06 | $10.05 | $10.78 | $10.43 |
| Selling, general & administrative | $39.11 | $36.01 | $35.83 | $34.08 |
| Total operating expenses | $49.17 | $46.06 | $46.61 | $44.52 |
| Operating income | -$14.37 | -$13.67 | -$14.32 | -$16.91 |
| Income from continuing operations | ||||
| EBIT | -$11.16 | -$11.01 | -$12.19 | -$14.52 |
| Income tax expense | ||||
| Interest expense | $1.73 | $1.73 | $1.71 | $1.69 |
| Net income | ||||
| Net income | -$12.89 | -$12.74 | -$13.9 | -$16.21 |
| Income (for common shares) | -$12.89 | -$12.74 | -$13.9 | -$16.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $177.13 | $138.64 | $101.47 | $75.23 |
| Cost of revenue | $50.05 | $37.88 | $25.45 | $21.29 |
| Gross Profit | $127.09 | $100.76 | $76.03 | $53.94 |
| Operating activities | ||||
| Research & development | $41.32 | $36.45 | $27.11 | $21.27 |
| Selling, general & administrative | $145.03 | $116.32 | $96.39 | $75.52 |
| Total operating expenses | $186.36 | $152.77 | $123.5 | $96.8 |
| Operating income | -$59.27 | -$52 | -$47.47 | -$42.86 |
| Income from continuing operations | ||||
| EBIT | -$48.87 | -$50.08 | -$47.33 | -$42.95 |
| Income tax expense | ||||
| Interest expense | $6.87 | $5.1 | $2.52 | $4.41 |
| Net income | ||||
| Net income | -$55.74 | -$55.18 | -$49.85 | -$47.37 |
| Income (for common shares) | -$55.74 | -$55.18 | -$49.85 | -$47.37 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$12.89 | -$12.74 | -$13.9 | -$16.21 |
| Operating activities | ||||
| Depreciation | $0.93 | $0.93 | $0.96 | $0.98 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.61 | $10.25 | $10.2 | $8.84 |
| Total cash flows from operations | -$8.45 | -$6.8 | -$4.62 | -$12.15 |
| Investing activities | ||||
| Capital expenditures | -$0.45 | -$0.33 | -$0.43 | -$0.29 |
| Investments | -$1.13 | $7.79 | -$18.72 | $6.39 |
| Total cash flows from investing | -$1.58 | $7.46 | -$19.16 | $6.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.05 | $0.13 | $1.59 | $1.11 |
| Net borrowings | ||||
| Total cash flows from financing | $1.05 | $0.13 | $1.59 | $1.11 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$8.98 | $0.79 | -$22.18 | -$4.93 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$55.74 | -$55.18 | -$49.85 | -$47.37 |
| Operating activities | ||||
| Depreciation | $3.79 | $3.17 | $1.92 | $1.39 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $38.89 | $25.02 | $14.61 | $7.23 |
| Total cash flows from operations | -$32.01 | -$32.58 | -$38.94 | -$42.07 |
| Investing activities | ||||
| Capital expenditures | -$1.51 | -$5 | -$4.76 | -$0.84 |
| Investments | -$5.67 | -$157.06 | $77.4 | -$8.55 |
| Total cash flows from investing | -$7.18 | -$162.07 | $72.64 | -$9.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.89 | $114.79 | $6.95 | $75.74 |
| Net borrowings | $24.91 | $6.01 | ||
| Total cash flows from financing | $3.89 | $139.7 | $6.98 | $81.75 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$35.3 | -$54.95 | $40.69 | $30.29 |
News
Fundamentals
| Market cap | $691.27M |
|---|---|
| Enterprise value | $746.69M |
| Shares outstanding | 39.17M |
| Revenue | $177.13M |
|---|---|
| EBITDA | -$45.08M |
| EBIT | -$48.87M |
| Net Income | -$55.74M |
| Revenue Q/Q | 17.97% |
| Revenue Y/Y | 27.77% |
| P/E ratio | -12.40 |
|---|---|
| EV/Sales | 4.22 |
| EV/EBITDA | -16.56 |
| EV/EBIT | -15.28 |
| P/S ratio | 3.90 |
| P/B ratio | 4.58 |
| Book/Share | 3.86 |
| Cash/Share | 0.52 |
| EPS | -$1.42 |
|---|---|
| ROA | -21.25% |
| ROE | -36.11% |
| Debt/Equity | 0.76 |
|---|---|
| Net debt/EBITDA | -2.08 |
| Current ratio | 7.95 |
| Quick ratio | 6.97 |